Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 233

1.
2.

Gene polymorphisms of tissue plasminogen activator and plasminogen activator inhibitor-1 in Turkish patients with generalized aggressive periodontitis.

Emingil G, Berdeli A, Gürkan A, Han Saygan B, Köse T, Atilla G.

J Clin Periodontol. 2007 Apr;34(4):278-84. Epub 2007 Jan 25.

PMID:
17257155
3.

Tissue plasminogen activator and plasminogen activator inhibitor-1 gene polymorphisms in patients with chronic periodontitis.

Gürkan A, Emingil G, Saygan BH, Cinarcik S, Atilla G, Köse T, Berdeli A.

J Periodontol. 2007 Jul;78(7):1256-63.

PMID:
17608581
4.

4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.

Sartori MT, Wiman B, Vettore S, Dazzi F, Girolami A, Patrassi GM.

Thromb Haemost. 1998 Dec;80(6):956-60.

PMID:
9869167
6.

[Plasminogen activator inhibitor-1 (PAI-1) 4G/5G and angiotensin converting enzyme (ACE) I/D gene polymorphisms and fibrinolytic activity in patients with essential hypertension and dyslipidemia].

Jastrzebska M, Widecka K, Ciechanowicz A, Goracy I, Wesołowska T, Torbus-Lisiecka B, Foltyńska-Nowakowska A, Naruszewicz M.

Pol Arch Med Wewn. 2005 Jan;113(1):7-20. Polish.

PMID:
16130596
7.

Role of the tissue-type plasminogen activator -7351C > T and plasminogen activator inhibitor 1 4G/5G gene polymorphisms in central serous chorioretinopathy.

Malle EM, Posch-Pertl L, Renner W, Pinter-Hausberger S, Singer C, Haas A, Wedrich A, Weger M.

Ophthalmic Genet. 2018 Dec;39(6):714-716. doi: 10.1080/13816810.2018.1536219. Epub 2018 Nov 15.

PMID:
30442055
8.

Association of tissue plasminogen activator and plasminogen activator inhibitor polymorphism with myocardial infarction: a meta-analysis.

Gong LL, Peng JH, Han FF, Zhu J, Fang LH, Wang YH, Du GH, Wang HY, Liu LH.

Thromb Res. 2012 Sep;130(3):e43-51. doi: 10.1016/j.thromres.2012.06.015. Epub 2012 Jul 6.

PMID:
22771216
9.

Association of PAI-1 4G/5G and -844G/A gene polymorphism and changes in PAI-1/tPA levels in stroke: a case-control study.

Saidi S, Slamia LB, Mahjoub T, Ammou SB, Almawi WY.

J Stroke Cerebrovasc Dis. 2007 Jul-Aug;16(4):153-9.

PMID:
17689411
10.

A study of the possible association of plasminogen activator inhibitor type 1 4G/5G insertion/deletion polymorphism with susceptibility to schizophrenia and in its subtypes.

Yenilmez C, Ozdemir Koroglu Z, Kurt H, Yanas M, Colak E, Degirmenci I, Gunes HV.

J Clin Pharm Ther. 2017 Feb;42(1):103-107. doi: 10.1111/jcpt.12470. Epub 2016 Oct 30.

PMID:
27796029
11.

The role of the t-PA I/D and PAI-1 4G/5G polymorphisms in African-American adults with a diagnosis of myocardial infarction or venous thromboembolism.

Hooper WC, Lally C, Austin H, Renshaw M, Dilley A, Wenger NK, Phillips DJ, Whitsett C, Rawlins P, Evatt BL.

Thromb Res. 2000 Aug 1;99(3):223-30.

PMID:
10942788
12.

The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism.

Stegnar M, Uhrin P, Peternel P, Mavri A, Salobir-Pajnic B, Stare J, Binder BR.

Thromb Haemost. 1998 May;79(5):975-9.

PMID:
9609232
13.

Plasminogen activator inhibitor 1 4G/5G and -844G/A variants in idiopathic recurrent pregnancy loss.

Magdoud K, Herbepin VG, Touraine R, Almawi WY, Mahjoub T.

Am J Reprod Immunol. 2013 Sep;70(3):246-52. doi: 10.1111/aji.12116. Epub 2013 Mar 22.

PMID:
23521508
14.

The plasminogen activator inhibitor (PAI-1) 4G/5G promoter polymorphism and PAI-1 levels in ischemic stroke. A case-control study.

van Goor ML, Gómez García E, Leebeek F, Brouwers GJ, Koudstaal P, Dippel D.

Thromb Haemost. 2005 Jan;93(1):92-6.

PMID:
15630497
15.

The plasminogen activator inhibitor (PAI)-1 promoter 4G/4G genotype is not associated with ischemic stroke in a population of German children. Childhood Stroke Study Group.

Nowak-Göttl U, Sträter R, Kosch A, von Eckardstein A, Schobess R, Luigs P, Nabel P, Vielhaber H, Kurnik K, Junker R.

Eur J Haematol. 2001 Jan;66(1):57-62.

PMID:
11168509
16.

PAI-1 4G/5G insertion/deletion promoter polymorphism and microvascular complications in type 2 diabetes mellitus.

Funk M, Endler G, Exner M, Marculescu R, Endler L, Abrahamian H, Mauler H, Grimm A, Raith M, Mannhalter C, Prager R, Irsigler K, Wagner OF.

Wien Klin Wochenschr. 2005 Oct;117(19-20):707-10.

PMID:
16416371
17.

Influence of PAI-1 gene promoter-675 (4G/5G) polymorphism on fibrinolytic activity after cardiac surgery employing cardiopulmonary bypass.

Ozolina A, Strike E, Jaunalksne I, Serova J, Romanova T, Zake LN, Sabelnikovs O, Vanags I.

Medicina (Kaunas). 2012;48(10):515-20.

18.
19.
20.

Supplemental Content

Support Center